Taiwo A. Ademoye

Taiwo A. Ademoye's work spans computational drug discovery methods (such as descriptor-free QSAR modeling to screen for potential drug candidates targeting a protein called FGFR1) and laboratory studies of plant-derived compounds, including phytochemical analysis and antioxidant testing of medicinal plants. The research touches on neuroscience-related topics like Alzheimer's and Parkinson's disease mechanisms, though recent publications focus more on drug-screening methods and natural product chemistry.

Publication output was sparse and irregular through the mid-2010s to early 2020s but has grown noticeably in recent years, with a marked increase in 2024-2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026